ARNI in cardiovascular disease: current evidence and future perspectives
PK Kuchulakanti - Future Cardiology, 2020 - Taylor & Francis
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are the
mainstay of therapy for cardiovascular disease and heart failure (HF). The angiotensin …
mainstay of therapy for cardiovascular disease and heart failure (HF). The angiotensin …
ARNI in cardiovascular disease: current evidence and future perspectives.
PK Kuchulakanti - Future Cardiology, 2020 - europepmc.org
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are the
mainstay of therapy for cardiovascular disease and heart failure (HF). The angiotensin …
mainstay of therapy for cardiovascular disease and heart failure (HF). The angiotensin …
ARNI in cardiovascular disease: current evidence and future perspectives
PK Kuchulakanti - Future cardiology, 2020 - pubmed.ncbi.nlm.nih.gov
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are the
mainstay of therapy for cardiovascular disease and heart failure (HF). The angiotensin …
mainstay of therapy for cardiovascular disease and heart failure (HF). The angiotensin …